Effect of Mepolizumab in severe bilateral nasal polypsThe purpose of this study is to assess the clinical efficacy and safety of 100 milligram subcutaneous mepolizumab as an add-on to maintenance treatment in adults with severe bilateral nasal polyps. Closed for Recruitment Principal Investigator Arif JanjuaBody Locations and Systems Nose Injuries and DisordersArea VancouverAge 18 and above
Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis (OSTRO)The purpose of this study is test the efficacy and safety of Benralizumab in patients with severe nasal polyposis. Closed for Recruitment Principal Investigator Arif JanjuaBody Locations and Systems Nose Injuries and DisordersArea VancouverAge 18 and above
